Format
Sort by
Items per page

Send to

Choose Destination

Best matches for adrenocortical carcinoma AND neoplasms:

Adrenocortical carcinoma: review and update. Erickson LA et al. Adv Anat Pathol. (2014)

Adrenocortical carcinoma. Else T et al. Endocr Rev. (2014)

Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis. Nakamura Y et al. Endocrinol Metab Clin North Am. (2015)

Search results

Items: 1 to 20 of 2816

1.

Synchronous adrenocortical carcinoma and ovarian malignant mixed germ cell tumor: A case report and literature review.

He Y, Xu L, Li Q, Feng M, Wang W.

Medicine (Baltimore). 2018 May;97(20):e10730. doi: 10.1097/MD.0000000000010730.

2.

Ghrelin as a potential molecular marker of adrenal carcinogenesis: In vivo and in vitro evidence.

Komarowska H, Rucinski M, Tyczewska M, Sawicka-Gutaj N, Szyszka M, Hernik A, Klimont A, Milecka P, Migasiuk L, Biczysko M, Idasiak-Piechocka I, Karczewski M, Ruchala M.

Clin Endocrinol (Oxf). 2018 Apr 23. doi: 10.1111/cen.13725. [Epub ahead of print]

PMID:
29682767
3.

Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography.

Thomas AJ, Habra MA, Bhosale PR, Qayyum AA, Ahmed K, Vicens R, Elsayes KM.

Abdom Radiol (NY). 2018 Apr 19. doi: 10.1007/s00261-018-1603-3. [Epub ahead of print]

PMID:
29671009
4.

MANAGEMENT OF ENDOCRINE DISEASE: Management of Cushing's syndrome during pregnancy: solved and unsolved questions.

Brue T, Amodru V, Castinetti F.

Eur J Endocrinol. 2018 Jun;178(6):R259-R266. doi: 10.1530/EJE-17-1058. Epub 2018 Mar 9. Review.

5.

MANAGEMENT OF ENDOCRINE DISEASE: Adrenocortical carcinoma: differentiating the good from the poor prognosis tumors.

Jouinot A, Bertherat J.

Eur J Endocrinol. 2018 May;178(5):R215-R230. doi: 10.1530/EJE-18-0027. Epub 2018 Feb 23. Review.

6.

[Pathogenic and diagnostic roles of microRNAs in adrenocortical tumours].

Nagy Z, Decmann Á, Perge P, Igaz P.

Orv Hetil. 2018 Feb;159(7):245-251. doi: 10.1556/650.2018.30919. Review. Hungarian.

PMID:
29429354
7.

Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.

Deng W, Qiu J, Wang S, Yuan Z, Jia Y, Tan H, Lu J, Zheng R.

Int J Nanomedicine. 2018 Jan 17;13:439-453. doi: 10.2147/IJN.S150977. eCollection 2018.

8.

Chronic primary adrenal insufficiency after unilateral adrenonephrectomy: A case report.

Yoshiji S, Shibue K, Fujii T, Usui T, Hirota K, Taura D, Inoue M, Sone M, Yasoda A, Inagaki N.

Medicine (Baltimore). 2017 Dec;96(51):e9091. doi: 10.1097/MD.0000000000009091.

9.

Anti-hMC2RL1 Functionalized Gold Nanoparticles for Adrenocortical Tumor Cells Targeting and Imaging.

Woiski TD, de Castro Poncio L, de Moura J, Orsato A, Bezerra AG Jr, Minozzo JC, de Figueiredo BC.

J Biomed Nanotechnol. 2017 Jan;13(1):68-76.

PMID:
29372993
11.

Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess.

Chortis V, Johal NJ, Bancos I, Evans M, Skordilis K, Guest P, Cullen MH, Porfiri E, Arlt W.

Eur J Endocrinol. 2018 Mar;178(3):K21-K27. doi: 10.1530/EJE-17-0542. Epub 2018 Jan 12.

12.

Oncocytic Adreno Cortical Tumors: Pathological Features of 16 Cases and Review of the Literature.

Ertan Y, Argon A, Özdemir M, Yürekli BPS, Dökümcü Z, Makay Ö.

J Environ Pathol Toxicol Oncol. 2017;36(3):237-244. doi: 10.1615/JEnvironPatholToxicolOncol.2017021895. Review.

PMID:
29283337
13.

Challenges in surgical pathology of adrenocortical tumours.

Erickson LA.

Histopathology. 2018 Jan;72(1):82-96. doi: 10.1111/his.13255. Review.

PMID:
29239032
14.

[A Case of Adrenal Leiomyosarcoma].

Taniguchi A, Ujike T, Fujita K, Uemura M, Kiuchi H, Imamura R, Miyagawa Y, Nonomura N, Morii E.

Hinyokika Kiyo. 2017 Nov;63(11):465-469. doi: 10.14989/ActaUrolJap_63_11_465. Japanese.

PMID:
29232797
15.

ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas.

Laufs V, Altieri B, Sbiera S, Kircher S, Steinhauer S, Beuschlein F, Quinkler M, Willenberg HS, Rosenwald A, Fassnacht M, Ronchi CL.

Eur J Endocrinol. 2018 Feb;178(2):183-190. doi: 10.1530/EJE-17-0788. Epub 2017 Nov 29.

PMID:
29187510
16.

Primary lesions that may imitate metastatic tumors histologically: A selective review.

Wick MR.

Semin Diagn Pathol. 2018 Mar;35(2):123-142. doi: 10.1053/j.semdp.2017.11.010. Epub 2017 Nov 17. Review.

PMID:
29174934
17.

Three cases of adrenocortical tumors mistaken for hepatocellular carcinomas/diagnostic pitfalls and differential diagnosis.

Park WY, Seo HI, Choi KU, Kim A, Kim YK, Lee SJ, Lee CH, Huh GY, Park DY.

Ann Diagn Pathol. 2017 Dec;31:9-13. doi: 10.1016/j.anndiagpath.2017.05.016. Epub 2017 May 29.

PMID:
29146062
18.

[Removal of giant adrenal tumors using the laparoscopic transperitoneal technique. A report of three successful cases].

Ottlakán A, Paszt A, Borda B, Simonka Z, Ábrahám S, Lázár G.

Orv Hetil. 2017 Nov;158(45):1802-1807. doi: 10.1556/650.2017.30910. Hungarian.

PMID:
29135271
19.

Less is more: cost-effectiveness analysis of surveillance strategies for small, nonfunctional, radiographically benign adrenal incidentalomas.

Chomsky-Higgins K, Seib C, Rochefort H, Gosnell J, Shen WT, Kahn JG, Duh QY, Suh I.

Surgery. 2018 Jan;163(1):197-204. doi: 10.1016/j.surg.2017.07.030. Epub 2017 Nov 9.

PMID:
29129360
20.

Calneuron 1 Increased Ca2+ in the Endoplasmic Reticulum and Aldosterone Production in Aldosterone-Producing Adenoma.

Kobuke K, Oki K, Gomez-Sanchez CE, Gomez-Sanchez EP, Ohno H, Itcho K, Yoshii Y, Yoneda M, Hattori N.

Hypertension. 2018 Jan;71(1):125-133. doi: 10.1161/HYPERTENSIONAHA.117.10205. Epub 2017 Nov 6.

PMID:
29109191

Supplemental Content

Loading ...
Support Center